Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
about
Alzheimer's disease--subcortical vascular disease spectrum in a hospital-based setting: Overview of results from the Gothenburg MCI and dementia studiesThe use of cerebrospinal fluid and neuropathologic studies in neuropsychiatry practice and researchHigh Resolution Discovery Proteomics Reveals Candidate Disease Progression Markers of Alzheimer's Disease in Human Cerebrospinal FluidUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Conversion Discriminative Analysis on Mild Cognitive Impairment Using Multiple Cortical Features from MR Images.Enrichment and stratification for predementia Alzheimer disease clinical trials.Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's diseaseClinical utility of cerebrospinal fluid biomarkers in the diagnosis of early Alzheimer's diseaseAnalysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.The Road Ahead to Cure Alzheimer's Disease: Development of Biological Markers and Neuroimaging Methods for Prevention Trials Across all Stages and Target PopulationsCerebrospinal Fluid Levels of Amyloid Beta 1-43 in Patients with Amnestic Mild Cognitive Impairment or Early Alzheimer's Disease: A 2-Year Follow-Up Study.Can MRI screen for CSF biomarkers in neurodegenerative disease?Fluid biomarkers in Alzheimer's disease - current conceptsHigh tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer's disease.Dynamics of biomarkers in relation to aging and mortality.CSF biomarker variability in the Alzheimer's Association quality control program.Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNIRisk factors for the progression of mild cognitive impairment to dementia.Interpreting Alzheimer's disease clinical trials in light of the effects on amyloid-β.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease.
P2860
Q26798325-8BF2B809-BB26-493B-B3AD-323B5BE0ED0DQ28088291-77ABEB0C-6A0B-4CFC-B290-D35864599FF5Q28547231-23A1D664-34C2-48C1-9ECA-8723D679382BQ30845482-9112B909-43EF-4C3C-95AF-39DDE5986AB7Q33701135-DCD4C0F1-D558-4B8B-B7B0-1FACB8DF80CAQ34452239-BC09CE3B-96A4-4FA0-8B27-9120CD73BC08Q35106997-36165C83-12A3-4A53-B70D-7227AB194FBFQ35284971-D1147ED5-B623-4EEB-86AD-1FF3E28ABF78Q35948036-0615722D-6C49-49B6-96D2-712DFCB5B609Q36165011-F7EDB659-90B3-4CCB-8692-FD05FF32A7CEQ36634198-FAADE052-5E6E-47ED-A4DD-F0153B2D00E3Q36659380-7188EADC-C2DC-4C28-9D46-7CF06DF85F93Q36953503-20BE3928-F372-4DC4-8334-79074BC0F12FQ36970998-0975FF09-E24C-4953-8276-ECEBA211B617Q36984319-C47356F7-67CC-4A25-A711-9E746020BE3CQ36999855-1F056B53-1569-49A6-9417-55288E6DE0A0Q37419658-2159A0E5-2BD4-41F1-A781-1F78D9C23FD5Q38149355-D8714DDF-F914-4C85-B9E9-628C242CE19EQ38230384-1EE62DFC-23D8-4452-AA29-47AE649FBF08Q47587631-ADC4DB0E-D794-4E79-BCE5-17037B51606DQ50532647-2B48A948-D7B7-4F6D-919C-D9D2ADC136E5
P2860
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@ast
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@en
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@nl
type
label
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@ast
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@en
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@nl
prefLabel
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@ast
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@en
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@nl
P2093
P50
P356
P1476
Longitudinal cerebrospinal fluid biomarkers over four years in mild cognitive impairment.
@en
P2093
Anders Wallin
Mats Stridsberg
Mikael Gustavsson
Ulf Andreasson
P304
P356
10.3233/JAD-2012-120019
P577
2012-01-01T00:00:00Z